Rosacea treatment
The rosacea or the full name is papulopustular rosacea, which is a skin condition that some people suffer from. This condition is very common in people with excess use of skincare products. This is an inflammatory condition and people suffering through this condition find the surface blood vessels of the face skin to be enlarged that gives a permanent appearance of being flushed. The effects are not limited to this and the forehead, cheeks, and chin may also develop yellow-headed pimples. However, rosacea pimples do not scar-like acne pimples. The condition is primarily found in women with some rare occurrences in men. The condition is most probable to occur between 30 years to 50 years of age and requires some treatment to make the skin better. If they are neglected then the symptoms and the condition can worsen over time. Till now there are some basic skincare therapies to help get rid of the disease and the market is ripe for any new technique to get rid of this condition that plagues more than 16 million people every year.
New treatment for rosacea
The company by the name of Botanix has gained approval on the ethical grounds to move ahead with its plan to develop a new treatment for rosacea, and the project is named BTX 1702. The approval was needed for the company to move into the phase 1b of the testing. The new technique will utilize the drug delivery system of Botanix known as the Permetrex. Two methods are being developed and both of them will be tested in the clinical trial phase.
The Permetrex that is the drug delivery system of the Botanix works differently than others. This drives the pharmaceuticals deep into the skin where the actions are required or else it remains on the outer layer of the skin and stays useless there. The next stage of the trials will be for testing the tolerability of the drug on the patients with severe cases of rosacea and the safety limit for the application of the drugs. The introduction of the new rosacea treatment technique in the market has caused a certain rise in the stock prices of the company and the future quarter of the market is predicted to rise further depending on the success of the new treatment and its availability all over the world. Value Market Research a market research company expects this market to showcase high demand due to rising cases of rosacea in the next six years.
Nishtha Sarabhai after working for three years in a Bank switched to writing to balance her work and home. She is a mother of two beautiful kids. She enjoys writing on Aerospace, Science and new invcentions. She has been with VMR news since its inception.